Catalytic Nucleic Acid Cleavage for RNA Capping Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for determining capping efficiency of in vitro-transcribed (IVT) mRNA are limited by the use of radioactive materials and lack precision, particularly for longer mRNA molecules, and existing biosensors provide capping level detection with low resolution, making them unsuitable for precise quality control in mRNA-based therapeutics.
Innovation Solution
A method involving catalytic nucleic acid molecules, such as ribozymes, that specifically cleave IVT mRNA at a unique position near the 5' end, producing distinct capped or uncapped 5' terminal fragments, allowing for accurate separation and analysis of capped RNA molecules, thereby enhancing sensitivity and accuracy in capping efficiency determination.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If RNase H cleavage method is used to analyze capping efficiency, then radioactivity is avoided, but the method generates multiple cleavage products of different lengths making analysis unreliable
Solution Approach 1:
The method segments the RNA molecule by cleaving it at a specific location using a catalytic nucleic acid, separating the capped 5' terminal fragment from the rest of the molecule. This segmentation allows selective analysis of only the capped fragments, eliminating interference from uncapped molecules and achieving precise capping efficiency measurement without radioactivity.
2Difficulty of detecting and measuring
If biosensor method is used to detect capping level, then the method provides detection capability, but the resolution is low with at least 20% increments making it imprecise
Solution Approach 1:
The method extracts and isolates the capped 5' terminal fragments from the total RNA population through selective cleavage and separation. By taking out only the capped fragments for analysis, the method achieves high precision measurement capability, overcoming the low resolution limitation of biosensor methods that cannot distinguish between different capping levels with fine granularity.
3Object-affected harmful factors
If LC-MS analysis is used to analyze cleaved fragments, then capping efficiency can be measured without radioactivity, but the method requires expensive equipment impacting affordability
Solution Approach 1:
The method replaces expensive LC-MS equipment with a simpler, more affordable detection approach using catalytic nucleic acid cleavage followed by standard separation techniques. The disposable nature of the catalytic nucleic acid reagents allows for cost-effective analysis without requiring sophisticated and expensive mass spectrometry instrumentation, making the method accessible to broader laboratories.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach enables fast, simple, and quantitative measurement of capping efficiency, improving the reproducibility and applicability of mRNA quality control in therapeutics by providing a more precise and sensitive method for analyzing RNA molecules with a 5' cap structure.
Implementation Method 1
contacting a catalytic nucleic acid molecule with a population of RNA molecules, which population comprises one or more RNA molecules comprising a cleavage site for the catalytic nucleic acid molecule and a 5′ cap structure, under conditions allowing the cleavage of the RNA molecules
Data Source
AI summary
The present invention relates to a method for analyzing the structure of 5′ terminus of an RNA molecule in a population of RNA molecules using catalytic nucleic acids, e.g., for determining the presence or absence of a 5′ cap structure.